March 18, 2020 -- Quidel has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to market its Lyra SARS-CoV-2 assay, a real-time reverse transcription polymerase chain reaction (RT-PCR) test for the novel coronavirus.
Quidel's Lyra line of products also includes PCR reagent kits. The Lyra SARS-CoV-2 assay is currently only available in the U.S., and it can be purchased through Quidel or Cardinal Health, the company said.
When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.Yes, Keep Me Current